BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 10403781)

  • 21. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
    Sowden MP; Eagleton MJ; Smith HC
    Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
    Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
    Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.
    Morrison JR; Pászty C; Stevens ME; Hughes SD; Forte T; Scott J; Rubin EM
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7154-9. PubMed ID: 8692961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin regulates the metabolism of low density lipoproteins by improving the C-to-U RNA editing efficiency of apolipoprotein B in primary rat hepatocytes.
    Tian N; Li X; Luo Y; Han Z; Li Z; Fan C
    Mol Med Rep; 2014 Jan; 9(1):132-6. PubMed ID: 24173373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA.
    Yang Y; Sowden MP; Yang Y; Smith HC
    Exp Cell Res; 2001 Jul; 267(2):153-64. PubMed ID: 11426934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition.
    Navaratnam N; Fujino T; Bayliss J; Jarmuz A; How A; Richardson N; Somasekaram A; Bhattacharya S; Carter C; Scott J
    J Mol Biol; 1998 Jan; 275(4):695-714. PubMed ID: 9466941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
    Yang Y; Sowden MP; Smith HC
    J Biol Chem; 2000 Jul; 275(30):22663-9. PubMed ID: 10833526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The APOBEC-2 crystal structure and functional implications for the deaminase AID.
    Prochnow C; Bransteitter R; Klein MG; Goodman MF; Chen XS
    Nature; 2007 Jan; 445(7126):447-51. PubMed ID: 17187054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing.
    Lau PP; Chan L
    J Biol Chem; 2003 Dec; 278(52):52988-96. PubMed ID: 14559896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular modelling of the biosynthesis of the RNA-editing enzyme APOBEC-1, responsible for generating the alternative forms of apolipoprotein B.
    Scott J; Navaratnam N; Carter C
    Exp Physiol; 1999 Jul; 84(4):791-800. PubMed ID: 10481235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene.
    Lau PP; Zhu HJ; Baldini A; Charnsangavej C; Chan L
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8522-6. PubMed ID: 8078915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
    Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
    J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing.
    Smith HC
    RNA Biol; 2017 Sep; 14(9):1153-1165. PubMed ID: 27869537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
    Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
    Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
    J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
    Severi F; Chicca A; Conticello SG
    Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing.
    Lau PP; Zhu HJ; Nakamuta M; Chan L
    J Biol Chem; 1997 Jan; 272(3):1452-5. PubMed ID: 8999813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed.
    Yamanaka S; Poksay KS; Balestra ME; Zeng GQ; Innerarity TL
    J Biol Chem; 1994 Aug; 269(34):21725-34. PubMed ID: 8063816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.
    Dance GS; Sowden MP; Yang Y; Smith HC
    Nucleic Acids Res; 2000 Jan; 28(2):424-9. PubMed ID: 10606639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.
    Fossat N; Tam PP
    RNA Biol; 2014; 11(10):1233-7. PubMed ID: 25585043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.